Skip to content
DataLookout
Menu

NCT07901088

A Bioequivalence and Safety Study of AJU-B718 and B718R in Healthy Adult Volunteers Under Fasting Conditions

StatusNot Yet Recruiting
PhasePhase 1
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

AUCt of AJU-B718
Timeframe: Pre-dose(0 hours) ~ 24 hours
Cmax of AJU-B718
Timeframe: Pre-dose(0 hours) ~ 24 hours

Secondary (4)

AUCinf of AJU-B718
Tmax of AJU-B718
t1/2 of AJU-B718
AUCt/AUCinf of AJU-B718

Arms and interventions

Sequence AExperimental

Period 1: Reference Drug, Single dose / Period 2: Test Drug, Single dose / Period 3: Reference Drug, Single dose / Period 4: Test Drug, Single dose

Sequence BExperimental

Period 1: Test Drug, Single dose / Period 2: Reference Drug, Single dose / Period 3: Test Drug, Single dose / Period 4: Reference Drug, Single dose

Drugs: Test Drug, Reference Drug

Sites

1 site in 1 country

  • H+ Yangji HospitalSeoul, Seoul, South Korea